Susquehanna International Securities’s AstraZeneca AZN Stock Holding History

Susquehanna International Securities’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,500	Closed	-$748K	–	89
2019 Q4	$748K	Sell	7,500 -70,950	-90%	-$6.68M	0.28%	54
2019 Q3	$6.99M	Buy	78,450 +66,950	+582%	+$5.81M	1.53%	20
2019 Q2	$949K	Buy	11,500 +4,000	+53%	+$314K	0.31%	56
2019 Q1	$606K	Sell	7,500 -11,800	-61%	-$930K	0.15%	63
2018 Q4	$1.47M	Buy	+19,300	New	+$1.51M	1.15%	21

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Securities's AZN Position: Q3 2024 in Review

Susquehanna International Securities opened a new position in AstraZeneca (AZN) in Q3 2024: 6,116 shares worth $953K. The stake represents 0.23% of the portfolio and ranks #30 among its holdings. This is a return to the name: Susquehanna International Securities previously reported a position in AZN as recently as Q1 2024.

Susquehanna International Securities first reported a position in AZN in Q4 2018 and has held it in 14 quarters since. The position peaked at $13.7M in Q4 2020. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

Susquehanna International Securities held 6,116 shares of AstraZeneca worth $953K as of Q3 2024.
AstraZeneca was a new Susquehanna International Securities position in Q3 2024.
AstraZeneca made up 0.23% of Susquehanna International Securities's portfolio in Q3 2024, its #30 holding.
Susquehanna International Securities first reported a position in AstraZeneca in Q4 2018 and has held it in 14 quarters since.
Susquehanna International Securities's AstraZeneca position peaked at $13.7M in Q4 2020.
1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on Susquehanna International Securities's 13F filing for Q3 2024, filed 14 Nov 2024.